Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Brain Metastases in Newly Diagnosed Breast Cancer

(2017) Allison M. Martin et al.   JAMA Oncology

A model for individualized risk prediction of contralateral breast cancer

(2016) Marzana Chowdhury et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic impact of breast cancer subtypes in elderly patients

(2016) E. S. Bergen et al.   BREAST CANCER RESEARCH AND TREATMENT

Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases

(2016) Minetta C. Liu et al.   CANCER AND METASTASIS REVIEWS

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases

(2015) Ishwaria M. Subbiah et al.   JOURNAL OF CLINICAL ONCOLOGY

The challenge of durable brain control in patients with brain-only metastases from breast cancer

(2015) Carsten Nieder et al.   SpringerPlus

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

(2014) I. E. Krop et al.   ANNALS OF ONCOLOGY

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

(2014) Naoki Niikura et al.   BREAST CANCER RESEARCH AND TREATMENT

Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer

(2012) Patrick G. Morris et al.   Breast Journal

Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer

(2012) Shaheenah Dawood et al.   CANCER

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

(2012) Nancy U. Lin et al.   CANCER

The shifting landscape of metastatic breast cancer to the CNS

(2012) Matthew R. Quigley et al.   NEUROSURGICAL REVIEW

Factors influencing survival in patients with breast cancer and single or solitary brain metastasis

(2011) A. Niwińska et al.   EJSO

Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases

(2011) Paul W. Sperduto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

(2010) G. Metro et al.   ANNALS OF ONCOLOGY

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)

(2009) A. Niwinska et al.   ANNALS OF ONCOLOGY

Prognosis of Patients with Triple-negative Breast Cancer and Brain Metastasis

(2009) R. Venkitaraman et al.   CLINICAL ONCOLOGY

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

(2009) Florian Heitz et al.   EUROPEAN JOURNAL OF CANCER

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer

(2008) S. L. Hines et al.   ANNALS OF ONCOLOGY

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer

(2008) Nancy U. Lin et al.   CANCER

Brain metastases: current management and new developments

(2008) Riccardo Soffietti et al.   CURRENT OPINION IN ONCOLOGY